Preclinical PK investigation of a novel IDO1/TDO dual inhibitor—SHR9146 in mouse plasma and tissues by LC-MS/MS

Overview of attention for article published in Frontiers in oncology, July 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 1 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 18,762 followers.

SHR9146 al PK investigation of a novel IDO1/TDO dual inhibitor—SHR9146 in mouse plasma and tissues by LC-MS/MS https://t.co/Ku6CFybvde https://t.co/7mgu6nNb3a

25 Aug 2023

Reply Repost Favourite

RT @FrontOncology: New research: Preclinical PK investigation of a novel IDO1/TDO dual inhibitor—SHR9146 in mouse plasma and tissues by LC-…

05 Aug 2023

Reply Repost Favourite

New research: Preclinical PK investigation of a novel IDO1/TDO dual inhibitor—SHR9146 in mouse plasma and tissues by LC-MS/MS: Purpose The aim of the present study was to establish a liquid chromatography–tandem mass spectrometry (LC-MS/MS)… #oncology htt

05 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.